Literature DB >> 24748649

'My child will never initiate Ultimate Harm': an argument against moral enhancement.

Ryan Tonkens.   

Abstract

Recently, there has been a lot of philosophical work published on the morality of moral enhancement. One thing that tends to get overlooked in this literature is that there are many different potential methods of morally enhancing humans, and a blanket moral assessment of them may not be warranted. Here I focus on one mode of moral enhancement, namely, prenatal genetic moral enhancement, and offer a normative assessment of it. I argue that there is good reason to adopt a parent-centred perspective (as opposed to a social or state-centred perspective) towards the ethics of prenatal genetic moral enhancement, and, once we do so, that there is good reason to argue that prenatal genetic attempts at moral enhancement are morally problematic and ought not to be pursued. The main reasons for this have to do with the nature of moral enhancement research, and the idea that prospective parents are justified in not assuming that their children will be morally depraved. I leave it open as to whether other modes of morally enhancing humans fare better, morally speaking. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Enhancement; Genetic Engineering; Minors/Parental Consent; Research Ethics

Mesh:

Year:  2014        PMID: 24748649     DOI: 10.1136/medethics-2013-101855

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  2 in total

1.  Smarter Than Thou, Holier Than Thou: The Dynamic Interplay Between Cognitive and Moral Enhancement.

Authors:  Gabriela Pavarini; Alex McKeown; Ilina Singh
Journal:  Front Pharmacol       Date:  2018-10-29       Impact factor: 5.810

2.  Commentary: Grand challenge: ELSI in a changing global environment.

Authors:  Ignacio Macpherson; Ignacio Segarra
Journal:  Front Genet       Date:  2017-09-26       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.